IGM Biosciences Inc. (IGMS) Tops Q4 EPS by 34c

IGM Biosciences Inc. (NASDAQ: IGMS) reported Q4 EPS of ($1.19), $0.34 better than the analyst estimate of ($1.53). Revenue for the quarter came in at $372 thousand versus the consensus estimate of $304.78 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15